miR-30b and miR-30c expression predicted response to tyrosine kinase inhibitors as first line treatment in non-small cell lung cancer

Yanfei Gu, Hui Zhang, Dan Su, Minli Mo, Pan Song, Fang Zhang, Shucai Zhang

Chinese Medical Journal · 2013 · 28 citations · 25 references

DOIFull text

Open access

Abstract

Our study identified miR-30b and miR-30c as useful prognostic predictors in NSCLC patients who underwent first line treatment with TKIs.

References

25